Gene mutations independent of BCR::ABL1 have been identified in newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase, whereby mutations in epigenetic modifier genes were most common. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.